The CIHR Strategic Master's Award program, supported by CIHR Institutes and Initiatives, provides financial support to students who are enrolled in or have applied to an eligible master's program in Canada that is relevant to specific CIHR priority research areas. This support allows these students to concentrate on their studies in their chosen fields.
Equity, Diversity and Inclusion
CIHR is committed to supporting a research environment that reflects the principles of equity, diversity and inclusion, and honors its commitment to reconciliation by strengthening the health and well-being of First Nations, Inuit and Métis Peoples. Achieving a more equitable, diverse and inclusive Canadian research enterprise is essential to creating the excellent, innovative and impactful research necessary to advance knowledge and understanding, and to responding to local, national and global challenges. Beyond efforts to bolster EDI, CIHR recognizes that First Nations, Métis and Inuit are rights-holding as First Peoples of Canada, and initiatives should be developed through distinctions-based approaches, as found in the strategic plan Setting new directions to support Indigenous research and research training in Canada.
Research Areas
This funding opportunity will support projects relevant to the following research areas:
Funds Available
CIHR and partner(s) financial contributions are subject to availability of funds. Should CIHR or partner(s) funding levels not be available or decrease due to unforeseen circumstances, CIHR and partner(s) reserve the right to reduce, defer or suspend financial contributions to awards received as a result of this funding opportunity.
CIHR reviewers heavily weight methodological rigor, including:
Strong theoretical framework
Clear hypotheses or research questions
Robust study design
Adequate controls, power calculations, and statistics
Reproducibility & transparency practices
Clear milestones and contingency plans
Predictor: Methodological strength is the #1 determinant across all CIHR committees.
CIHR prioritizes research that benefits:
The health of people living in Canada
Canadian healthcare systems and policies
Vulnerable or underserved populations
Chronic disease burdens in Canadian demographics
Predictor: Clear articulation of Canadian relevance dramatically improves scores.
Successful CIHR proposals:
Have 2–3 well-defined aims
Present realistic deliverables within the grant period
Include detailed methodologies for each aim
Avoid overambitious or unfocused scope
Demonstrate precise timeline and project management
Predictor: Feasibility + clarity of approach = high reviewer confidence.
Reviewers value:
Publications relevant to the field
Prior successful funding
Expertise aligned to each aim
Multi-disciplinary teams (clinicians, statisticians, biomedical scientists, policy experts)
For early-career investigators: mentorship, protected time, and institutional support
Predictor: A well-matched, credible team is essential.
Highly competitive CIHR proposals commonly include:
Pilot experiments or feasibility data
Retrospective analyses
Early mechanistic insights
Proof-of-concept findings
For high-risk or exploratory programs, strong rationale can substitute, but evidence is still preferred.
Predictor: Preliminary data significantly boosts chances.
CIHR explicitly evaluates EDI in:
Team composition
Training environment
Research design (sex, gender, intersectionality, inclusive sampling)
Barriers to participation or recruitment
Engagement with under-represented or Indigenous populations
Predictor: Meaningful EDI integration is essential; weak EDI sections lower scores.
CIHR places high value on:
How findings will reach clinicians, policymakers, communities, or the public
Realistic KT activities (briefs, publications, engagement, partnerships)
Integrated knowledge translation when applicable (co-design with stakeholders)
Predictor: Strong KT plan with defined stakeholders and products.
High success when aligned with:
Indigenous health
Digital health & AI
Aging and dementia
Chronic disease (cancer, cardiovascular, neurological)
Rare disease
Implementation science
Mental health, substance use
Health system strengthening
Predictor: Direct strategic alignment increases competitiveness.
CIHR reviewers look for feasibility evidence:
Confirmed clinical recruitment sites
Existing cohort or biobank access
Computational / lab infrastructure
Letters of support verifying data access
Agreements for collaboration or sharing
Predictor: Proven resource availability reduces perceived risk.
Successful budgets:
Are lean and proportional to aims
Avoid unnecessary equipment or inflated salaries
Align with Canadian Tri-Council rules
Include justification for trainees, supplies, analyses
Predictor: A clear, efficient budget strengthens feasibility.
| Pitfall | Why It Hurts |
|---|---|
| Vague or overly ambitious aims | Feasibility concerns |
| Weak or missing preliminary data | Too speculative |
| Poor methodology or unclear analytic plan | Low rigor |
| Minimal relevance to Canadian health | Weak significance |
| Poor EDI integration | Fails mandatory criteria |
| No KT or weak dissemination plan | Low potential impact |
| Unclear roles of team members | Execution risk |
| Overinflated budget | Reviewer concerns |
For an application to be eligible, all the requirements stated below must be met.
Sponsor Institute/Organizations: Canadian Institutes of Health Research
Sponsor Type: Corporate/Non-Profit
Address: 234 Laurier Ave West, Ottawa, ON K1A 0K9
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 14, 2026
Jan 14, 2026
$19,170
Affiliation: Canadian Institutes of Health Research
Address: 234 Laurier Ave West, Ottawa, ON K1A 0K9
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.